John E. (Jack) Bailey Jr., President and CEO at G1 Therapeutics, Inc. (GTHX), sold 65,966 shares at $3.27 ($216K) on 2024-01-02, disclosed to the SEC on 2024-01-02.
Seasonal sale ($216k) by President and CEO — this insider has traded GTHX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.27 | 32,983 | $108K | 50.0% |
| 2 | $3.27 | 32,983 | $108K | 50.0% |
| Total | $3.27 avg | 65,966 | $216K | 100% |
| Filing → |
| GTHX | SELL | 2024-01-08 | $36K | — | Filing → |
| GTHX | SELL | 2023-07-07 | $7K | — | Filing → |
| GTHX | SELL | 2023-01-05 | $406K | — | Filing → |